fluoxetine has been researched along with Hyperphagia in 9 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Hyperphagia: Ingestion of a greater than optimal quantity of food.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine is a selective serotonin reuptake inhibitor that often is associated with a modest weight loss when used for the treatment of depression, although it also has been reported to have the opposite effects of weight gain and hyperphagia in some patients." | 7.69 | Hyperphagia and weight loss during fluoxetine treatment. ( Braun, BG; Fichtner, CG, 1994) |
| " Then, the authors also examined the effect of subchronic treatment for 21 days with fluoxetine on clozapine-induced hyperphagia and modulation of body weight and fat pad weights." | 3.71 | Studies on modulation of feeding behavior by atypical antipsychotics in female mice. ( Kaur, G; Kulkarni, SK, 2002) |
| "Fluoxetine is a selective serotonin reuptake inhibitor that often is associated with a modest weight loss when used for the treatment of depression, although it also has been reported to have the opposite effects of weight gain and hyperphagia in some patients." | 3.69 | Hyperphagia and weight loss during fluoxetine treatment. ( Braun, BG; Fichtner, CG, 1994) |
| "Pretreatment with seganserin, a 5-HT(2) receptor antagonist (2 mg/kg, i." | 1.31 | Evidence for serotonergic modulation of progesterone-induced hyperphagia, depression and algesia in female mice. ( Kaur, G; Kulkarni, SK, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miryala, CS | 1 |
| Maswood, N | 1 |
| Uphouse, L | 1 |
| Fichtner, CG | 1 |
| Braun, BG | 1 |
| Jordaan, GP | 1 |
| Roberts, MC | 1 |
| Emsley, RA | 1 |
| Bhatia, MS | 1 |
| Choudhary, S | 1 |
| Devlin, MJ | 1 |
| Goldfein, JA | 1 |
| Carino, JS | 1 |
| Wolk, SL | 1 |
| Kaur, G | 3 |
| Kulkarni, SK | 3 |
| Geracioti, TD | 1 |
| Loosen, PT | 1 |
| Gold, PW | 1 |
| Kling, MA | 1 |
1 trial available for fluoxetine and Hyperphagia
| Article | Year |
|---|---|
Open treatment of overweight binge eaters with phentermine and fluoxetine as an adjunct to cognitive-behavioral therapy.
Topics: Adult; Appetite Depressants; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Therapy, | 2000 |
8 other studies available for fluoxetine and Hyperphagia
| Article | Year |
|---|---|
Fluoxetine prevents 8-OH-DPAT-induced hyperphagia in Fischer inbred rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anorexia; Eating; Estradiol; Female; Fluoxetine; Hy | 2011 |
Hyperphagia and weight loss during fluoxetine treatment.
Topics: Adult; Depression; Eating; Female; Fluoxetine; Humans; Hyperphagia; Weight Loss | 1994 |
Serotonergic agents in the treatment of hypothalamic obesity syndrome: a case report.
Topics: Adult; Body Weight; Brain Damage, Chronic; Dose-Response Relationship, Drug; Fenfluramine; Fluoxetin | 1996 |
Kleine-Levin syndrome--a case report with a brief review.
Topics: Adult; Antidepressive Agents, Second-Generation; Fluoxetine; Humans; Hyperphagia; Kleine-Levin Syndr | 1996 |
Investigations on possible serotonergic involvement in effects of OB-200G (polyherbal preparation) on food intake in female mice.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Disease Models, Animal; Energy Intake; Feeding Beha | 2001 |
Studies on modulation of feeding behavior by atypical antipsychotics in female mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adipose Tissue; Animals; Antipsychotic A | 2002 |
Evidence for serotonergic modulation of progesterone-induced hyperphagia, depression and algesia in female mice.
Topics: Analgesics; Animals; Antidepressive Agents, Second-Generation; Brain; Depression; Disease Models, An | 2002 |
Cortisol, thyroid hormone, and mood in atypical depression: a longitudinal case study.
Topics: Adult; Affect; Depressive Disorder; Disorders of Excessive Somnolence; Female; Fluoxetine; Humans; H | 1992 |